Today's stock in focus in Medtronic, a medical technology company.
MDT's P/E ratio value compared to SYK, and STJ says it is at a discount. Lower than average volatility compared to S&P. Cash flow is below average. Liquidity is below average, but that is due to a large amount of assets. No insider activity this month. Yearly growth estimate of 51.99%, higher than industry. However 5 year growth outlook is meek. Dividend yield could be more appealing. Looks like a healthy stock.
MDT's P/E ratio value compared to SYK, and STJ says it is at a discount. Lower than average volatility compared to S&P. Cash flow is below average. Liquidity is below average, but that is due to a large amount of assets. No insider activity this month. Yearly growth estimate of 51.99%, higher than industry. However 5 year growth outlook is meek. Dividend yield could be more appealing. Looks like a healthy stock.
Shares rising due to pumping before ex-dividend date of 4/6/2011. Low yield makes this point moot, but expect a minor decline after that due to low volume and lack of support. The company is beginning to push new products, and adjusting to new management. Downsides include layoffs and the long-term effect of the 6-8% of business in Japan. Macroeconomic effect of employment report this friday will determine the price movement this week.
Price shouldn't climb much higher in the next 15 days. However, I do expect this stock to value at 41 by May. Long term, it is a secure stock for a year play.
No comments:
Post a Comment